19-12897705-C-A
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM1BP4_StrongBP6_Very_StrongBS2
The NM_000159.4(GCDH):c.1085C>A(p.Ala362Asp) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000888 in 1,614,112 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A362V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000159.4 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| GCDH | NM_000159.4 | c.1085C>A | p.Ala362Asp | missense_variant, splice_region_variant | Exon 11 of 12 | ENST00000222214.10 | NP_000150.1 | |
| GCDH | NM_013976.5 | c.1085C>A | p.Ala362Asp | missense_variant, splice_region_variant | Exon 11 of 12 | NP_039663.1 | ||
| GCDH | NR_102316.1 | n.1248C>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 11 of 12 | ||||
| GCDH | NR_102317.1 | n.1466C>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 10 of 11 | 
Ensembl
Frequencies
GnomAD3 genomes  0.00423  AC: 643AN: 152134Hom.:  4  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.00119  AC: 298AN: 251392 AF XY:  0.00104   show subpopulations 
GnomAD4 exome  AF:  0.000539  AC: 788AN: 1461860Hom.:  3  Cov.: 32 AF XY:  0.000479  AC XY: 348AN XY: 727236 show subpopulations 
Age Distribution
GnomAD4 genome  0.00424  AC: 645AN: 152252Hom.:  4  Cov.: 31 AF XY:  0.00419  AC XY: 312AN XY: 74436 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Glutaric aciduria, type 1    Benign:3 
- -
- -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
not provided    Benign:2 
- -
- -
Inborn genetic diseases    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
GCDH-related disorder    Benign:1 
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at